Research & Impact
We are a group of epidemiologist, behavioural scientists and statisticians studying the causes of or early events in the development of cancer.
We are comprised of three groups:
We evaluate current approaches to screening and study new screening technologies.
We study how to optimise the efficacy and cost-effectiveness and minimise the harms of screening programmes by generating evidence on:
- We are studying vaginal self-sampling which may improve cervical screening coverage.
- We are working with Professor Fitzgerald’s group in Cambridge on the BEST3 study. This investigates the potential of a Cytosponge to screen for Barrett’s oesophagus and reduce mortality from adenocarcinoma of the oesophagus.
- We will assess polygenic risk with the goal of developing risk-based personalised screening intervals for breast and prostate cancer.
Our core funding is provided by Cancer Research UK.
Browser does not support script.